Daclatasvir Dihydrochloride and Necon
Determining the interaction of Daclatasvir Dihydrochloride and Necon and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclatasvir
Brand name: Daklinza
Synonyms: Daclatasvir
Generic Name: conjugated estrogens / medroxyprogesterone
Brand name: Premphase, Prempro
Synonyms: Conjugated estrogens and medroxyprogesterone, Estrogens (Conjugated/Equine) and Medroxyprogesterone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclatasvir Dihydrochloride-Necon 0.5/35
- Daclatasvir Dihydrochloride-Necon 1/35
- Daclatasvir Dihydrochloride-Necon 1/50
- Daclatasvir Dihydrochloride-Necon 1/50 (28)
- Daclatasvir Dihydrochloride-Necon 7/7/7
- Daclatasvir Dihydrochloride-Nedocromil Inhalation, oral/nebulization
- Necon-Daclizumab
- Necon-Daclizumab Subcutaneous
- Necon-Dacogen
- Necon-Dacomitinib
- Necon-Dactinomycin
- Necon-Dactinomycin Injection